NasdaqGS - Delayed Quote • USD
QuidelOrtho Corporation (QDEL)
At close: April 25 at 4:00 PM EDT
After hours: April 25 at 6:22 PM EDT
Earnings Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 7 | 7 | 7 | 7 |
Avg. Estimate | 0.52 | 0.02 | 2.4 | 3.72 |
Low Estimate | 0.25 | -0.25 | 1.8 | 2.87 |
High Estimate | 0.73 | 0.22 | 2.77 | 4.87 |
Year Ago EPS | 1.8 | 0.26 | 4.13 | 2.4 |
Revenue Estimate
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
No. of Analysts | 7 | 7 | 7 | 7 |
Avg. Estimate | 695.04M | 644.43M | 2.79B | 2.9B |
Low Estimate | 681.9M | 632.17M | 2.72B | 2.75B |
High Estimate | 712M | 661M | 2.86B | 2.99B |
Year Ago Sales | 794.05M | 615.16M | 3B | 2.79B |
Sales Growth (year/est) | -12.50% | 4.80% | -7.10% | 4.30% |
Earnings History
CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
---|---|---|---|---|
EPS Est. | 1.49 | 0.28 | 0.6 | 2.05 |
EPS Actual | 1.8 | 0.26 | 0.9 | 1.17 |
Difference | 0.31 | -0.02 | 0.3 | -0.88 |
Surprise % | 20.80% | -7.10% | 50.00% | -42.90% |
EPS Trend
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Current Estimate | 0.52 | 0.02 | 2.4 | 3.72 |
7 Days Ago | 0.58 | 0.05 | 2.46 | 3.92 |
30 Days Ago | 0.71 | 0.11 | 2.59 | 3.88 |
60 Days Ago | 0.7 | 0.14 | 2.56 | 3.95 |
90 Days Ago | 1.49 | 0.62 | 5.07 | 5.99 |
EPS Revisions
CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
---|---|---|---|---|
Up Last 7 Days | -- | 1 | -- | -- |
Up Last 30 Days | 1 | 1 | -- | 1 |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | 2 | 1 | 2 | 2 |
Growth Estimates
CURRENCY IN USD | QDEL | Industry | Sector | S&P 500 |
---|---|---|---|---|
Current Qtr. | -71.10% | -- | -- | 2.60% |
Next Qtr. | -92.30% | -- | -- | 13.40% |
Current Year | -41.90% | -- | -- | 5.20% |
Next Year | 55.00% | -- | -- | 13.30% |
Next 5 Years (per annum) | 7.20% | -- | -- | 11.11% |
Past 5 Years (per annum) | 8.43% | -- | -- | -- |
Research Analysis
Upgrades & Downgrades
Downgrade | UBS: Neutral to Sell | 3/4/2024 |
Downgrade | Craig-Hallum: Buy to Hold | 2/14/2024 |
Maintains | RBC Capital: Outperform to Outperform | 2/14/2024 |
Downgrade | Raymond James: Strong Buy to Outperform | 2/14/2024 |
Downgrade | William Blair: Outperform to Market Perform | 2/14/2024 |
Downgrade | JP Morgan: Neutral to Underweight | 2/14/2024 |
Related Tickers
IART Integra LifeSciences Holdings Corporation
28.41
-3.30%
NARI Inari Medical, Inc.
38.07
-0.29%
BIO Bio-Rad Laboratories, Inc.
275.60
-0.94%
PODD Insulet Corporation
164.17
-1.84%
CNMD CONMED Corporation
61.90
-11.58%
NVCR NovoCure Limited
12.23
-0.89%
NVRO Nevro Corp.
11.62
-7.11%
TNDM Tandem Diabetes Care, Inc.
35.56
+1.25%
INSP Inspire Medical Systems, Inc.
231.01
-1.36%
BRKR Bruker Corporation
80.59
-1.96%